Physician profile
Muhammad Ali
NPI 1508898362
$793.43
in general payments reported to CMS, 2019-2025
11 companies · $24.88 in 2025
The $24.88 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $71.16 · 2022: $110 · 2023: $334 · 2024: $253 · 2025: $24.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $612.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $177.00 | 2021-2025 | Rybelsus, Ozempic |
| Nevro Corp. | $133.12 | 2024 | Senza |
| Ethicon INC. | $130.76 | 2023 | Monarch Platform |
| Baxter Healthcare | $125.92 | 2023-2024 | Renal - Pd |
| Philips North America LLC | $55.70 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $52.10 | 2023 | Inpefa |
| Astellas Pharma US INC | $30.59 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $27.25 | 2024 | Eliquis |
| Stemline Therapeutics INC. | $22.32 | 2024 | Orserdu |
| Abiomed | $20.86 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $17.81 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.